Search results
Results from the WOW.Com Content Network
Blackmores Limited is an Australian health supplements company founded in 1938 by naturopath Maurice Blackmore (1906–1977), when Blackmore opened the first health food shop in Australia in Brisbane. [1] [2] It manufactures an extensive range of vitamin, mineral and herbal supplements, sold in 17 markets [3] across the Asia Pacific region.
13861 Ensembl ENSG00000121053 ENSMUSG00000052234 UniProt P11678 P49290 RefSeq (mRNA) NM_000502 NM_007946 RefSeq (protein) NP_000493 NP_031972 Location (UCSC) Chr 17: 58.19 – 58.21 Mb Chr 11: 87.75 – 87.77 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Eosinophil peroxidase is an enzyme found within the eosinophil granulocytes, innate immune cells of humans and mammals. This ...
Allusive to the alchemical feat of palingenesis by Paracelsus, the phrase "ghost of a rose" was first stated in the penultimate paragraph of the physician-philosopher Thomas Browne's 1658 discourse The Garden of Cyrus which concludes, "...and though in the Bed of Cleopatra, can hardly with any delight raise up the ghost of a Rose".
Rule 139 EPC relates to a specific form of amendments, namely corrections of errors in documents filed with the EPO. Rule 139 EPC contains two sentences, the first one providing for that, in general, "[l]inguistic errors, errors of transcription and mistakes in any document filed with the European Patent Office may be corrected on request", and ...
This is a list of decisions and opinions of the Enlarged Board of Appeal of the European Patent Office (EPO) in chronological order of their date of issuance. The list includes decisions under Article 112(1)(a) EPC (following a referral from a Board of Appeal), opinions under Article 112(1)(b) EPC (following a referral from the President of the EPO), "to ensure uniform application of the law ...
In the United States, an exclusive provider organization (EPO) is a hybrid health insurance plan in which a primary care provider is not necessary, but health care providers must be seen within a predetermined network. Out-of-network care is not provided, and visits require pre-authorization.
Continuous erythropoietin receptor activator (CERA) is the generic term for drugs in a new class of third-generation erythropoiesis-stimulating agents (ESAs). In the media, these agents are commonly referred to as 'EPO', short for erythropoietin.
Erythropoietin in neuroprotection is the use of the glycoprotein erythropoietin (Epo) for neuroprotection. Epo controls erythropoiesis, or red blood cell production. Erythropoietin and its receptor were thought to be present in the central nervous system according to experiments with antibodies that were subsequently shown to be nonspecific.